Literature DB >> 15227039

Direct myocardial revascularization without extracorporeal circulation: technique and initial results.

E Buffolo1, J C Andrade, J E Succi, L E Leão, C Cueva, J N Branco, A C Carvalho, C Galluci.   

Abstract

In a 10-month period, 68 patients underwent saphenous vein bypass revascularization without extracorporeal circulation. Distal sutures were performed with interruption of coronary flow without any devices for perfusion of the coronary artery; the proximal sutures were completed with tangential clamping of the aorta. Most frequently, the anterior descending and the distal right coronary arteries were revascularized; of 225 patients who underwent bypass surgery, this technique was possible in 68 cases (30.2%). The 30-day hospital mortality was 1.5%, and perioperative myocardial infarction, as determined by daily electrocardiograms (ECGs) and creatine phosphokinase isoenzyme (CKMB), occurred in two patients. Control hemodynamic studies were performed in 22 of the 68 patients (32.4%) with a patency rate of 84.2% in the grafts restudied.

Entities:  

Year:  1985        PMID: 15227039      PMCID: PMC341789     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  5 in total

1.  Placement of coronary artery bypass graft without pump oxygenator.

Authors:  W G Trapp; R Bisarya
Journal:  Ann Thorac Surg       Date:  1975-01       Impact factor: 4.330

2.  Saphenous vein autograft replacement of severe segmental coronary artery occlusion: operative technique.

Authors:  R G Favaloro
Journal:  Ann Thorac Surg       Date:  1968-04       Impact factor: 4.330

3.  Extended treatment of severe coronary artery disease: a total surgical approach.

Authors:  W D Johnson; R J Flemma; D Lepley; E H Ellison
Journal:  Ann Surg       Date:  1969-09       Impact factor: 12.969

4.  Saphenous vein graft in the surgical treatment of coronary artery disease. Operative technique.

Authors:  R G Favaloro
Journal:  J Thorac Cardiovasc Surg       Date:  1969-08       Impact factor: 5.209

5.  [Direct revascularization of the myocardium without extracorporeal circulation. Description of the technic and preliminary results].

Authors:  E Buffolo; J C Andrade; J E Succi; L E Leão; C Cueva; J N Branco; C Gallucci
Journal:  Arq Bras Cardiol       Date:  1982-05       Impact factor: 2.000

  5 in total
  3 in total

1.  Indications and problems of coronary artery bypass grafting without cardiopulmonary bypass.

Authors:  K Kondo; S Minohara; Y Sawada; H Irie; K Okamoto; S Kinugasa; M Nakao; S Sasaki
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

2.  Coronary Artery Bypass Surgery in Brazil: Analysis of the National Reality Through the BYPASS Registry.

Authors:  Rodrigo Pereira Paez; Nelson Américo Hossne Junior; José Amalth do Espírito Santo; Otavio Berwanger; Renato Hideo Nakagawa Santos; Renato Abdala Karam Kalil; Fabio B Jatene; Alexandre Biasi Cavalcanti; Alexandre Cabral Zilli; Luiz Carlos Bettiati; Fernando Augusto Marinho Dos Santos Figueira; Stephanie Steremberg Pires D'Azevedo; Marcelo José Ferreira Soares; Marcio Pimentel Fernandes; Roberto Vito Ardito; Renata Andrea Barberio Bogdan; Valquíria Pelisser Campagnucci; Diana Nakasako; Clarissa Garcia Rodrigues; Anilton Bezerra Rodrigues Junior; Marcelo Matos Cascudo; Fernando Antibas Atik; Elson Borges Lima; Vinicius José da Silva Nina; Renato Albuquerque Heluy; Lisandro Gonçalves Azeredo; Odilon Silva Henrique Junior; José Teles de Mendonça; Katharina Kelly de Oliveira Gama Silva; Marcelo Pandolfo; José Dantas de Lima Júnior; Renato Max Faria; Jonas Gonçalves Dos Santos; Guilherme Henrique Biachi Coelho; Sergio Nunes Pereira; Roberta Senger; Enio Buffolo; Guido Marco Caputi; Juliana Aparecida Borges de Oliveira; Walter J Gomes
Journal:  Braz J Cardiovasc Surg       Date:  2019 Mar-Apr

3.  Comparative study on the enhancement of ischemic tolerance by intracoronary pretreatment with three calcium antagonists in pig hearts.

Authors:  H H Klein; S Pich; S Lindert; K Nebendahl; H Kreuzer
Journal:  Cardiovasc Drugs Ther       Date:  1989-01       Impact factor: 3.727

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.